Thermo Fisher Scientific (TMO) Financial Analysis & Valuation | Quarter Chart
Thermo Fisher Scientific (TMO)
TMOPrice: $506.42
Fair Value: 🔒
🔒score
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instrumen... more
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty di... more
Description
Shares
| Market Cap | $188.20B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Marc N. Casper |
| IPO Date | 1980-03-17 | CAGR | 0.14% |
| Employees | 125,000 | Website | www.thermofisher.com |
| Div. Yield | 0.31% | Payout Ratio | 0.09% |
| Buy Back Yield | 1.88% | Total Yield | 2.19% |
TMO chart loading...
Fundamentals
Technicals
| Enterprise Value | $237.60B | P/E Ratio | 21.87 |
| Forward P/E | 18.58 | PEG Ratio | 2.46 |
| P/S Ratio | 4.71 | P/B Ratio | 4.1 |
| P/CF Ratio | 25.68 | P/FCF Ratio | 31.51 |
| EPS | $23.16 | EPS Growth 1Y | 6.75% |
| EPS Growth 3Y | 18.66% | EPS Growth 5Y | -8.41% |
| Revenue Growth 1Y | 5.36% | Gross Margin | 0.39% |
| Operating Margin | 0.18% | Profit Margin | 0.15% |
| ROE | 0.13% | ROA | 0.06% |
| ROCE | 0.08% | Current Ratio | 1.53 |
| Quick Ratio | 1.15 | Cash Ratio | 0.22 |
| Debt/Equity | 0.83 | Interest Coverage | 5.46 |
| Altman Z Score | 3.32 | Piotroski Score | 5 |